Industry News

44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience

By HospiMedica International staff writers
19 Nov 2021

Image: 44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience (Photo courtesy of IHF)

The 44th World Hospital Congress (WHC) organized by The International Hospital Federation (IHF; Geneva, Switzerland) on 8-11 November 2021 in Barcelona, Spain came to an upbeat close.


During the event, which was held a year later than originally planned due to the COVID-19 pandemic, public health leaders and hospital CEOs in Europe and North America exchanged ideas on how organizations can prepare for the next global pandemic, alongside building more resilient healthcare systems. For the first time, the event was fully hybrid, facilitating the participation of more than 1,200 in-person and 300 online delegates from over 70 countries. For four days, leaders and decision-makers in the healthcare community shared knowledge and good practices, exchanged new ideas and innovations, and networked with other senior executives.


The theme for the 44th World Hospital Congress was, “People on board: Transforming healthcare by blending agility, responsiveness, and resilience”. During the event delegates shared many lessons and experiences from the COVID-19 pandemic. Alongside this hospital leaders were keen to build upon those experiences and implement strategies that can help mitigate mass public health issues in the future.


The highlights of the program included:



  • An Opening Ceremony keynote address by Dr. Hans Kluge, Regional Director for Europe of the World Health Organization, who paid tribute to health and care workers: “I want to ask you to convey – on behalf of WHO – a message of gratitude, respect and support to the teams you lead and their families, for the commitment, altruism and resilience you have all shown in the past two years.”



  • Public health leaders and hospital CEOs in Europe and North America exchanging ideas on getting ready for the next global pandemic. Hospital Clínic de Barcelona’s CEO-Clinical Hospital, Prof. Josep M. Campistol, shared that: “We need an integrated healthcare system if we are to be ready for the next global pandemic. This involves using artificial intelligence, digital technology and new IT infrastructures.” Meanwhile, Vaccinations Coordinator at The White House/USG, Dr Bechara Choucair, ended his virtual presentation with a reminder and challenge: “We already have the tools. We just have to finish the job with the truth, science… and confidence.”



  • Key stakeholders from industry, government and public health shared the lessons to learn from accelerating research, development and distribution of the COVID-19 vaccine. Dr. John Nkengasong, Director of Africa Centres for Disease Control and Prevention, shared the vaccine situation in Africa: “Vaccine hesitancy is not a problem here. The key challenge we have in the content is access to vaccines and how to get predictable access to vaccines.” and called for a new public health order for Africa.



  • Leaders in nursing outlined their critical contribution to transforming healthcare during a worldwide pandemic. Dr. Maria Eulàlia Juvé Udina, Board Member at International Council of Nurses, Nurse Executive at the Catalan Institute of Health, and Nurse Researcher at IDIBELL Universitat de Barcelona, shared that: “Even before COVID-19, there was already the imbalance between required hours by patients and available professional nursing hours.” This imbalance weakens hospitals resulting to situations like poor care quality and clinical outcomes, and even higher mortality.



  • A European-focused session explored ways to adopt, implement and scale up the organizational and technological innovations to come from the pandemic. Led by Dr. Josep Figueras, Director of the European Observatory on Health Systems and Policies, who emphasized the power of collaborations between hospitals and stated: “The innovation is the implementation of the existing innovation.”



  • Also, during the event the IHF launched a Special Interest Group on “Leadership for Sustainability”, teaming up with Deloitte to support healthcare leaders in taking action on climate change and the winners in each of six prestigious categories of the IHF Awards 2021 were announced at a special ceremony.


The WHC is the premier event in the IHF’s calendar and the organizing partner and host for the 44th World Hospital Congress was La Unió Catalana d’Hospitals (UCH). The 45th World Hospital Congress will take place in Dubai (UAE) on 9-11 November 2022.


Related Links:
The International Hospital Federation 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

06 Dec 2021
IHF to Launch Geneva Centre of Healthcare Leadership for Sustainability
The International Hospital Federation (IHF; Geneva, Switzerland) is preparing to launch the Geneva Centre of Healthcare Leadership for Sustainability (the Centre) in 2022 in response to the need for hospitals and healthcare services to address climate change.
Read More
06 Dec 2021
Global Mammography Market to Reach USD 3.4 Billion in 2028 Due To Increasing Prevalence of Breast Cancer
The global mammography market is expected to reach USD 3.4 billion in 2028, driven by the increasing prevalence of breast cancer across the globe, rising government fund for ongoing research on breast cancer, and increasing public awareness about cancer. The market growth is being fueled further by increasing number of screening programs and campaigns to create awareness about breast cancer, improving healthcare infrastructure and facilities, and technological advancements in breast imaging techniques.
Read More
03 Dec 2021
Global HBA1c Laboratory Tests Market Driven by Rise in Diabetic Population
The global HBA1c laboratory tests market is projected to expand at a significant pace over the coming years, driven by an increase in the prevalence of diabetes, rise in prescription rate of HBA1c tests by physicians, low price of tests, and awareness about complications of high diabetes levels.
Read More
02 Dec 2021
Roche Completes Acquisition of TIB Molbiol Group
Roche (Basel, Switzerland) has completed its share purchase agreement to acquire 100% of the outstanding shares of TIB Molbiol Group (Berlin, Germany).
Read More
02 Dec 2021
Siemens Partners with Biotech Company Freenome to Develop Blood Test for Early Breast Cancer Detection
Siemens Healthineers (Erlangen, Germany) and Freenome (South San Francisco, CA, USA) have entered into a collaboration in multiomics and radiomic breast cancer diagnostics to identify suitable markers for early breast cancer detection through blood to augment existing imaging technologies.
Read More
01 Dec 2021
Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing
The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3.7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow assay kits, demand growth of point-of-care testing, and rise in adoption of LFA kits due to their advantages over laboratory tests.
Read More
30 Nov 2021
Global Chemiluminescence Immunoassay (CLIA) Analyzers Market to Surpass USD 7.5 Billion by 2025
The global chemiluminescence immunoassay (CLIA) analyzers market is estimated to grow at a CAGR of 6.4% in the forecast period of 2020-2025 to reach USD 7.6 billion by 2025, with the reagents segment anticipated to capture almost three-fourth of the overall CLIA analyzers market and reach USD 5.7 billion by the end of 2025.
Read More
29 Nov 2021
Global Fluoroscopy Equipment Market to Top USD3.5 Billion by 2031 Due to Demand for Multipurpose Imaging Tools
The global fluoroscopy equipment market is projected to grow at a CAGR of 6% from an estimated USD 1.9 billion in 2021 to surpass USD 3.5 billion by the end of 2031, driven by surging applications of fluoroscopy equipment across various medical fields such as cardiology, nephrology, urology, and others.
Read More
25 Nov 2021
Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases
The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic cases, technological developments in point of care devices and increased investments by the key players.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions